BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 20382250)

  • 21. Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?
    Churg A; Sin DD; Wright JL
    Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1111-5. PubMed ID: 21685155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast cells and COPD.
    Mortaz E; Folkerts G; Redegeld F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):367-72. PubMed ID: 21463700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Chronic Obstructive Pulmonary Disease Caused by Wood Smoke a Different Phenotype or a Different Entity?
    Torres-Duque CA; García-Rodriguez MC; González-García M
    Arch Bronconeumol; 2016 Aug; 52(8):425-31. PubMed ID: 27207325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review.
    Comandini A; Marzano V; Curradi G; Federici G; Urbani A; Saltini C
    Pulm Pharmacol Ther; 2010 Dec; 23(6):482-92. PubMed ID: 20594977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cigarette smoking is the most important causal factor for developing chronic obstructive pulmonary disease (COPD)].
    Muro S
    Nihon Rinsho; 2011 Oct; 69(10):1735-40. PubMed ID: 22073565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobacco smoking and environmental risk factors for chronic obstructive pulmonary disease.
    Salvi S
    Clin Chest Med; 2014 Mar; 35(1):17-27. PubMed ID: 24507834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological changes in the COPD lung mesenchyme--novel lessons learned from in vitro and in vivo studies.
    Ojo O; Lagan AL; Rajendran V; Spanjer A; Chen L; Sohal SS; Heijink I; Jones R; Maarsingh H; Hackett TL
    Pulm Pharmacol Ther; 2014 Dec; 29(2):121-8. PubMed ID: 24747433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of smoking on the pathogenesis of COPD].
    Tatsumi K
    Nihon Rinsho; 2007 Apr; 65(4):605-10. PubMed ID: 17419375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differences and similarities between occupational and tobacco induced COPD].
    Soumagne T; Caillaud D; Degano B; Dalphin JC
    Rev Mal Respir; 2017 Jun; 34(6):607-617. PubMed ID: 28506727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of chronic obstructive pulmonary disease and its association with tobacco smoking and environmental tobacco smoke exposure among rural population.
    Parasuramalu BG; Huliraj N; Prashanth Kumar SP; ; Ramesh Masthi NR; Srinivasa Babu CR
    Indian J Public Health; 2014; 58(1):45-9. PubMed ID: 24748357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspects on pathophysiological mechanisms in COPD.
    Larsson K
    J Intern Med; 2007 Sep; 262(3):311-40. PubMed ID: 17697154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The etiologic origins for chronic obstructive pulmonary disease.
    Huang X; Mu X; Deng L; Fu A; Pu E; Tang T; Kong X
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1139-1158. PubMed ID: 31213794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling COPD in mice.
    Vlahos R; Bozinovski S; Gualano RC; Ernst M; Anderson GP
    Pulm Pharmacol Ther; 2006; 19(1):12-7. PubMed ID: 16286233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden and clinical features of chronic obstructive pulmonary disease (COPD).
    Pauwels RA; Rabe KF
    Lancet; 2004 Aug 14-20; 364(9434):613-20. PubMed ID: 15313363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of chronic obstructive pulmonary disease as an epidemic in India.
    Jindal SK
    Indian J Med Res; 2006 Dec; 124(6):619-30. PubMed ID: 17287549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking.
    Montaño M; Cisneros J; Ramírez-Venegas A; Pedraza-Chaverri J; Mercado D; Ramos C; Sansores RH
    Inhal Toxicol; 2010 Aug; 22(10):868-74. PubMed ID: 20583895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.
    Bateman ED; Feldman C; O'Brien J; Plit M; Joubert JR;
    S Afr Med J; 2004 Jul; 94(7 Pt 2):559-75. PubMed ID: 15283307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Etiological and exacerbation factors for COPD. Air pollution].
    Ogawa K; Kishi K
    Nihon Rinsho; 2016 May; 74(5):743-6. PubMed ID: 27254939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production.
    Winkler AR; Nocka KN; Williams CM
    Pulm Pharmacol Ther; 2012 Aug; 25(4):286-92. PubMed ID: 22613758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.